How Methotrexate Affects Kidneys in Older Adults
Methotrexate, a folate antagonist used for rheumatoid arthritis, cancer, and psoriasis, is cleared primarily by the kidneys. In elderly patients (typically over 65), age-related declines in glomerular filtration rate (GFR) slow its elimination, raising blood levels and toxicity risk. This leads to higher rates of acute kidney injury (AKI), often from crystal precipitation in renal tubules or direct tubular damage.[1][2]
Standard low-dose regimens (7.5-25 mg/week for arthritis) are usually safe if GFR exceeds 60 mL/min, but risks climb sharply below 50 mL/min. High-dose IV therapy (common in oncology) requires aggressive hydration and leucovorin rescue to prevent AKI, which occurs in up to 10-20% of cases without precautions.[3]
Why Elderly Kidneys Are More Vulnerable
Aging reduces renal blood flow by 40-50% and GFR by 1 mL/min per year after 40, shrinking renal reserve. Methotrexate's active metabolite, 7-hydroxymethotrexate, accumulates in low-GFR states, worsening nephrotoxicity. Dehydration, common in seniors, exacerbates crystal formation. Comorbidities like diabetes, hypertension, or NSAID use (often co-prescribed for arthritis) compound this, with studies showing 2-5x higher AKI odds in those over 75.[1][4]
Monitoring and Dosing Adjustments
Guidelines recommend baseline creatinine clearance (CrCl) via Cockcroft-Gault formula before starting. Hold or reduce dose if CrCl <60 mL/min; avoid high doses if <30 mL/min. Weekly monitoring of serum creatinine, BUN, and methotrexate levels is standard. Folic acid supplementation (1-5 mg/day) mitigates some risks without reducing efficacy.[2][5]
| CrCl (mL/min) | Recommended Adjustment |
|---------------|-------------------------|
| ≥60 | No change |
| 30-59 | 25-50% dose reduction |
| 10-29 | Avoid or dialyze |
| <10 | Contraindicated |[3]
Common Kidney Side Effects and Reversal
Acute effects include rising creatinine (within 48 hours of high dose), oliguria, and flank pain. Chronic low-dose use links to mild GFR declines over years, reversible upon discontinuation. Hemodialysis effectively removes methotrexate if started early (within 24 hours).[4][6] Recovery rates exceed 90% with prompt intervention, but elderly patients face higher dialysis needs and mortality (up to 20% in severe AKI).[1]
Who Should Avoid It and Alternatives
Contraindicated in end-stage renal disease or unstable kidney function. Alternatives include biologics like TNF inhibitors (e.g., etanercept) for arthritis, which have lower renal impact, or leflunomide. For cancer, switch to less nephrotoxic agents like pemetrexed with caution.[5][7]
Sources
[1]: UpToDate: Methotrexate nephrotoxicity
[2]: American College of Rheumatology Guidelines
[3]: NEJM: High-dose methotrexate renal toxicity
[4]: PubMed: Methotrexate in elderly CKD
[5]: FDA Label: Methotrexate
[6]: Kidney International: MTX removal by dialysis
[7]: Arthritis Foundation: MTX alternatives